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Objectives: This study sought to examine how patients‘ mood and quality of life 
(QoL) change during the early high risk period after a diagnosis of heart failure (HF) 
and to identify factors that may influence change. 
Design: A within-subjects, repeated-measures design was used. Assessments took 
place within 4 weeks of diagnosis and six months later. 
Methods: 166 patients with HF completed assessments of their mood, QoL and 
beliefs about HF and its treatment. Correlation analysis was conducted between the 
variables and ANOVA and t-tests were used to assess differences in categorical 
variables. To examine which variables predicted mood and QoL, hierarchical multiple 
regressions were conducted including all significant variables identified from the 
bivariate analyses. 
Results: At follow-up, patients‘ beliefs indicated a realisation of the chronicity of 
their HF, however their beliefs about the consequences of having HF did not change 
and their satisfaction with their treatment remained high. Quality of life and anxiety 
improved significantly over time but there was no significant change in depressed 
mood. As would be expected, improvement in symptoms was a key factor in 
improved mood and QoL. Other significant explanatory variables included age, 
comorbid chronic obstructive pulmonary disease (COPD), depressed mood, patients‘ 
beliefs about the consequences of their HF and their concerns about treatment.  
Conclusions: This study suggests that addressing patients‘ mood and beliefs about 
their illness and its treatment may be additional ways of improving patient QoL in the 
early period after the diagnosis of heart failure. 
 
 
 
*Main document (inc. abstract, figs and tables)
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Introduction 
Heart failure is a global health-care issue affecting at least 15 million patients across 
the United States (US) (Hunt, 2005) and Europe (Swedberg et al., 2005). In the 
United Kingdom (UK), approximately 2% of the general population live with definite 
or probable heart failure (British Heart Foundation, 2002; Davies et al., 2001). A 
further 1-2% of the general population (or approximately 60,000 people) develops 
incident (new) heart failure annually (Cowie et al., 1999; 2002).  
The prognosis after a new diagnosis of heart failure in the general population 
is poor with particularly high mortality rates in the first few months after diagnosis 
(Cowie et al., 2000; 2002; Ho et al., 1993). Although prognosis has improved in the 
past decade, perhaps due to improvements in diagnosis and medical therapy, early 
mortality remains unacceptably high (Levy et al., 2002; Mehta et al., 2008; 2009). 
This early high risk period is a time when the health care system is investing 
considerable effort and resources to stabilise patients‘ clinical condition, organise a 
management plan and initiate and titrate drug therapy.  
Patients with HF are amongst the patient groups most likely to show 
compromised QoL. In comparison to other chronic illnesses such as arthritis, 
myocardial infarction, angina, and chronic obstructive pulmonary disease as well as 
the healthy population, HF patients appear to have the lowest QoL scores (Hobbs et 
al., 2002). Specifically, these patients face difficulties in their social life, problems 
with their personal relationships, and dealing with the number of physical limitations 
(Jaarsma et al., 1999). 
There is also evidence of a high prevalence of anxiety and depression in the 
HF population. A meta-analytic review by Rutledge et al. (2006) suggested that 21.6% 
of HF patients experience clinically significant depression, whereas individual studies 
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report prevalence rates ranging from 9% to 60%. The explanation for this discrepancy 
in findings may be the consideration of clinically significant depression versus 
depressive symptomatology assessed with questionnaires. On the other hand, although 
there is sparse evidence in relation to anxiety, the findings support prevalence rates 
between 40% and 63% depending on the subgroup of HF patients assessed (Konstam 
et al., 2005).  
Research to date on mood and QoL in HF has focussed on patients with 
established disease. Less is known about the experiences of people newly diagnosed 
with heart failure and how their mood and QoL may change in the early period after 
diagnosis, when treatment is introduced and optimised.   
Many factors are likely to influence how patients adapt to a chronic illness 
such as heart failure. One of those factors is the beliefs people hold about their 
condition. When people are faced with an illness condition such as heart failure, they 
create mental representations in order to make sense of and manage their problem. 
The above notion is the basic assumption of the common-sense model (CSM) of 
illness representations proposed by Leventhal, Meyer, and Nerenz (1980). The illness 
representations dimensions in the theory are: 1) Identity, the disease label and its 
associative symptoms; 2) Timeline, whether the disease is acute, cyclic, or chronic; 3) 
Causes such as genes, infection, stress, fate; 4) Consequences; and 5) Perceived 
controllability/curability (Leventhal et al., 1998). According to the theory, the 
representations people form lead to the choice of coping procedures to manage their 
illness, which in turn are evaluated in relation to the expected outcomes such as QoL 
(Leventhal et al., 1992).  
In addition to the illness representations people form general treatment 
representations. These treatment representations have in turn been found to have four 
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attributes: 1) Treatment value, which is the capacity of the specific treatment regime 
to control the condition; 2) Treatment concern; 3) Decision satisfaction, which is the 
satisfaction with the chosen treatment; and 4) Cure, which is the ability of the 
treatment to resolve the condition (Hirani et al., 2008). 
  Taking into account these representations helps to explain why patients who 
appear to have disease of similar severity may cope in different ways and report 
differing impact of their condition on their QoL. Patients‘ views of their illness arise 
not only from the information they receive from health professionals and other 
sources but also from their own experiences of the illness. Leventhal et al. (1998) 
argue that people are in ―constant interaction with and processing information‖ from 
their social context. Heart failure is a chronic, continuously changing condition with a 
variety of symptom experiences and different treatment pathways. As such, illness 
beliefs are not static but are likely to change as patients‘ experience of their illness 
changes over time.  
From diagnosis and with the initiation of treatment in HF, it is to be expected 
that these beliefs will change and thus influence adaptation. While changes in 
symptoms would be expected to influence mood and QoL, an important question is 
whether the way people view their illness and its treatment in this early phase after 
diagnosis also has an influence on health-related outcomes. A better understanding of 
how patients with HF think about their condition in the difficult early period at the 
time of diagnosis, and how this changes over time and influences mood and QoL, 
would enhance our ability to develop better ways to support patients through this time. 
  
To assess changes in beliefs and adaptation soon after diagnosis and changes 
in QoL, we examined patients‘ beliefs and adaptation to HF at the time of diagnosis 
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and again 6 months after diagnosis in a population-based study conducted in South-
east England. A full description of the parent study has been reported previously 
(Mehta et al., 2008; 2009), but briefly, the study recruited all individuals with a new 
diagnosis of heart failure from June 2004 to October 2005 in the geographical area 
served by Hillingdon Hospital, West London and the Conquest Hospital, Hastings. 
The primary aims of the study were to determine the mode of death on patients in the 
early period after diagnosis, and to compare prognosis with previous epidemiological 
studies in the same geographical area (Cowie et al., 2000; Fox et al., 2001). 
 
Methods 
Design 
A within-subjects, repeated-measures design was used. Baseline questionnaire 
assessments were completed within 4 weeks of first presentation with heart failure 
and repeated 6 months later.  
 
Participants and recruitment 
Patients were recruited from the districts shared by two UK general hospitals, The 
Hillingdon Hospital, West London and The Conquest Hospital, East Sussex. All 
patients who received a first time diagnosis of heart failure, on their attendance at an 
out-patient clinic or during hospital admission, were eligible for the study. Heart 
failure was diagnosed according to European Society of Cardiology criteria (Remme 
& Swedberg, 2002). 
Patients were excluded if they did not speak English, were too unwell, and had 
a current psychiatric disorder or clear evidence of cognitive impairment, which would 
have made completion of the assessments impossible.  
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Questionnaire Assessments 
Quality of life was assessed using the Minnesota Living with Heart Failure 
Questionnaire (MLHF) (Rector et al., 1987). This provides a total score and also two 
subscales for physical and emotional quality of life. In meta-analysis, the MLHF was 
shown to have satisfactory internal consistency (Cronbach‘s alpha 0.94 [95% 
Confidence Interval (CI): 0.91–0.95], test-retest reliability (Intraclass correlation = 
0.84) and responsiveness (Garin et al, 2009). 
Patients‘ beliefs about their heart failure were assessed with the Illness 
Perception Questionnaire (IPQ) (Weinman et al., 1996), which assesses beliefs in 5 
domains: (i) identity – the symptoms the person perceives to be related to the illness. 
The core illness identity symptom list published in Weinman et al (1996) was 
extended to include some of the common signs and symptoms of heart failure (ii) 
cause – beliefs about what caused the illness (iii) timeline – perception of the likely 
time course, (iv) consequences – perception of the effect of the illness, (v) 
cure/control – beliefs about how amenable the illness is to cure and/or control. This 
paper focuses on the scores for the major dimensions; patients‘ beliefs regarding 
causes are not included. The IPQ has been shown to have satisfactory internal 
consistency and test re-test reliability and to be able to differentiate between different 
illness conditions (Weinman et al 1996). 
 Patients‘ beliefs about their treatment were assessed using the Treatment 
Representations Inventory (TRI) (Hirani et al., 2008), which assesses beliefs in four 
domains: (i) treatment value - beliefs about the positive effects of their treatment in 
controlling and arresting the progress of their illness, (ii) concerns – emotional impact 
and concerns about treatment, (iii) cure – patients‘ beliefs about the ability of the 
treatment to resolve the illness and return them to their normal life, (iv) decision 
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satisfaction – patients‘ evaluation of the decision process for choosing their treatment. 
This measure has been shown to have satisfactory internal consistency and to be able 
to discriminate between treatments among a population of cardiac patients (Hirani et 
al, 2008). 
Patients‘ mood was assessed with the Hospital Anxiety and Depression Scale 
(HADS) (Zigmond & Snaith, 1983). This scale provides separate scores for anxiety 
and depression. Scores of 8 or above indicate possible clinical anxiety/depression 
while scores of 11 or above indicate probable clinical anxiety/depression. The HADS 
is widely used and has been validated with cardiac patients (Herrmann, 1997). 
 
Clinical assessments 
Clinical variables included echocardiographic evaluation of global systolic function 
and presence of comorbid illness. New York Heart Association (NYHA) 
classification was recorded at both time points.  
 
Analysis 
Power calculations were performed using GPower 3.0.8. All other statistical analyses 
were performed using SPSS 15.0 for Windows. The bivariate relationship between 
variables was examined by correlations (Pearson r correlations for continuous 
variables, Spearman‘s rho for ordinal variables). In the case of categorical 
independent variables (e.g. gender), differences between categories in QoL and mood 
were examined by t-test or analysis of variance (ANOVA), as applicable. To examine 
which variables accounted for most variance in mood and QoL, hierarchical multiple 
regressions using stepwise method were performed. The independent variables were 
entered into the regression in blocks in the following order:  1. demographic variables, 
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2. clinical variables, 3. patients‘ beliefs about their illness and treatment. Mood was 
entered into the regressions in which QoL was the dependent variable as a further 
block. This order was used because it enables examination to be made as to whether 
psychosocial variables add to the explanation of the dependent variables once the 
routinely recorded demographic and clinical variables have been taken into account.  
 
Ethics 
The investigation conforms to the principles outlined in the Declaration of Helsinki. 
The study received approval from the hospitals‘ Ethics Committees. All patients gave 
written informed consent.  
 
Results 
Sample 
A total of 396 patients participated in the parent study, of whom 210 (53%) completed 
the questionnaires at baseline. Participants were younger (median age 72 versus 75, p 
= 0.01), had a greater percentage of males (66% versus 56%, p<0.05) and had 
increased LV size (5.9 cm versus 5.6 cm, p<0.05) than non-participants. There was no 
difference between participants and non-participants in baseline NYHA class or left 
ventricular (LV) function (assessed either by ejection fraction or where this was not 
possible by visual assessment of left ventricular function by an experienced operator – 
classified as good (no left ventricular systolic dysfunction), fair (mild to moderate 
dysfunction) or poor (severe dysfunction) (Choy et al., 1994). 
 Of those who completed baseline questionnaires, 17 (8%) died within the 
follow-up period. One hundred and sixty-six (86% of surviving patients) completed 
all questionnaire assessments at both baseline and six-month follow-up and are 
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included in the analysis for this paper. Baseline characteristics of the 166 patients who 
completed questionnaires at both time points are shown in Table 1.  
 A comparison of baseline values of illness beliefs, treatment beliefs, mood and 
QoL was made between survivors and those who had died. No significant differences 
were found.  
 
Change in symptoms between diagnosis and 6-month follow-up 
NYHA classification at diagnosis and follow-up are shown in Table 2. At the 6-month 
follow-up assessment NYHA classification had improved in 141 (85%) patients, 
remained unchanged in 22 (13%) and deteriorated in 3 (2%).  
 At baseline, the most commonly reported symptoms which patients considered 
to be associated with heart failure (IPQ Identity) were fatigue, breathlessness, loss of 
strength, dry mouth, swollen ankles, sleep difficulties and a dry cough. The total 
number of reported symptoms which patients attributed to HF reduced significantly 
from a mean of 9.17 (SD 4.19) at baseline to 7.90 (SD 4.43), p≤.001 at six-months. 
The largest reduction was in the reporting of swollen ankles (Figure 1). 
 
Change in quality of life between diagnosis and 6-month follow-up 
Mean quality of life scores, as measured by MLHF, improved between baseline and 6 
months (Table 3). The total score and both sub-scales (physical and emotional) 
showed significant improvement over time.  Physical QoL improved in 69% of 
patients, remained unchanged in 5% and deteriorated in 26%. Corresponding 
percentages for emotional QoL were 70%, 12% and 18%.  
 
Change in mood between diagnosis and 6-month follow-up 
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At baseline, 37% of patients scored within the range of ‘possible’ clinical anxiety (a 
score of ≥8), of whom 12% were within the ‘probable’ clinical anxiety range (a score 
of ≥11). At 6 months, these had reduced to 11.4% and 10.2% respectively (Sign test, 
Z= -3.02, p = 0.003). The corresponding percentages for depression were 18% 
‘possible’ cases and 6% ‘probable’ cases at baseline reducing to 10.2% and 4.8% 
respectively at 6 months (Sign test, Z = -0.63, p = 0.53). Mean anxiety scores for the 
whole sample reduced significantly over time but depression scores did not change 
(Table 3). Mean anxiety scores improved in 55% of patients, remained unchanged in 
14% and worsened in 31%. Corresponding percentages for depression were 43%, 20% 
and 37%. 
 
Change in illness beliefs between diagnosis and 6-month follow-up 
At baseline, patients generally held positive beliefs about the ability of HF to be cured 
or controlled. There was more variation in beliefs about the consequences and 
perceived duration of HF (‗IPQ Timeline‘). Patients‘ beliefs in how amenable HF was 
to cure or control weakened over time and the perceived duration of HF increased. 
Despite these changes, patients‘ beliefs regarding the consequences of their HF did 
not change significantly (Table 3).  
 
Change in treatment beliefs between diagnosis and 6-month follow-up 
At baseline, patients generally held positive beliefs about the value of their treatment 
and were satisfied with the treatment decisions that had been made. Patients‘ beliefs 
in the curative power of their treatment weakened significantly over time, as did their 
concerns about treatment, but this did not impact on their satisfaction with the 
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treatment decisions that had been made or on how much they valued their treatment 
(Table 3). 
 
Factors associated with changes in mood and quality of life 
To examine the factors that may influence changes in mood and quality of life, two 
sets of multiple regression analyses were performed. The first analysis looked at the 
extent to which change in quality of life and mood could be predicted from baseline 
variables. The second analysis examined the extent to which changes in symptoms 
and patients‘ illness and treatment beliefs accounted for changes in quality of life and 
mood. In these analyses residualised change scores were calculated for NYHA, QoL, 
mood, illness and treatment beliefs to control for the level of these variables at 
baseline. Results of the regression analyses are shown in Tables 4, 5, & 6. Post hoc 
tests of achieved power are shown for each of the regression analyses. 
 
To what extent do baseline variables predict change in mood and quality of life? 
An analysis of baseline predictors of changes in outcomes may lead to an early 
identification of individuals at ―risk‘. However very few baseline variables were 
associated with change in either anxiety or depression in bivariate analysis. 
Consequently no multivariate analysis was performed on these outcomes.   
Baseline variables did account for a small percentage of the variance in change 
in QoL (12% and 14% of the variance in change in physical and emotional QoL 
respectively). Table 4 shows baseline predictors of change in the total QoL score and 
also the physical and emotional subscales. Older patients reported more improvement 
in emotional QoL. Less improvement in physical and emotional QoL was reported by 
those with a diagnosis of COPD or hypertension. Patients who perceived greater 
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consequences of their illness at baseline reported less improvement in emotional QoL. 
Those who were more anxious at baseline reported less improvement in physical QoL.  
 
To what extent do changes in symptoms and beliefs predict change in mood and 
quality of life?  
The regression analysis examining the relationship between changes in symptoms and 
beliefs and changes in anxiety and depression is shown in Table 5. Greater reduction 
in anxiety in the 6 months following a diagnosis of HF was reported by patients who 
reported greater reduction in a) the number of symptoms they associated with heart 
failure (IPQ Identity), b) perceived severity of the consequences of their HF, c) 
perceived amenability of HF to control/cure and d) concerns about treatment. Greater 
reduction in depression was reported by patients who showed greater improvement in 
a) NYHA, and greater reduction in b) self-reported symptoms (IPQ Identity) c) 
perceived severity of consequences of their illness and d) increasing belief in the 
ability of treatment to manage the illness. 
The regression analysis examining the relationship between change in 
symptoms and beliefs and change in QoL is shown in Table 6. Greater improvement 
in total QoL score was reported by patients who did not have COPD, those with more 
improvement in NYHA, and greater reduction in a) self-reported symptoms (IPQ 
‗Identity‘), b) perceived consequences of the illness and c) depression. Changes in 
beliefs about treatment were not significant in the final equation. There was some 
difference between the QoL subscales in significant predictor variables. Age and 
change in anxiety were predictive of change in emotional but not physical QoL, 
whereas change in severity of perceived illness consequences was predictive of 
change in physical but not emotional QoL. Changes in NYHA, self-reported 
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symptoms and also changes in depression were predictive of change in both physical 
and emotional QoL. 
 
Discussion 
This study has shown that patients report significant reductions in levels of anxiety 
and improvements in QoL in the six months following the diagnosis of HF. These 
changes were accompanied by changes in beliefs that reflected patients‘ growing 
recognition of HF as a chronic illness, as they perceived HF to be longer lasting and 
less curable at the 6-month follow-up than at baseline. A similar change was found by 
Astin et al (2006) in a study of patients‘ illness representations before and 6-8 months 
after undergoing elective percutaneous transluminal coronary angioplasty. Despite the 
realisation of the chronicity of their HF, patients did not change their beliefs about the 
consequences of having HF, and their satisfaction with their treatment remained high. 
Furthermore, the concerns about treatment that were expressed soon after diagnosis 
lessened over time. These findings are reassuring about the impact of early 
information and treatment of patients with heart failure.  
The ability to predict how well people diagnosed with HF will adapt over time 
would be a great advantage in directing support to those in greatest need. In this study, 
however, overall baseline variables showed little ability to predict mood or QoL in the 
subsequent six months. However, having a co-morbid diagnosis of COPD resulted in 
less improvement in both physical and emotional QoL. It is possible that this may 
reflect the more limited capacity to improve symptoms in such patients. Of the 
baseline psychological factors, only the severity of perceived consequences predicted 
change in QoL, where those patients who perceived their illness to have had greater 
consequences reported less improvement in their emotional QoL 6 months later. This 
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finding is in line with the findings of a previous meta-analysis indicating that 
perceptions of more negative consequences result in a more diminished psychosocial 
functioning (Hagger & Orbell, 2003). Addressing the early beliefs about the 
consequences of HF in those who hold particularly negative views at the time of 
diagnosis may be a useful strategy in assisting patients to have improved QoL.   
The extent of the reduction in patients‘ anxiety over the 6 month period was 
associated with reductions in their concerns regarding treatment. It is perhaps 
understandable that many patients will have concerns about starting new medications 
but these might be expected to reduce over time as their treatment becomes familiar 
and they derive benefits from it. This finding highlights the independent role of 
patients‘ concerns about treatment and its effect on mood. Addressing patients‘ 
concerns about their treatment at the time of diagnosis may be an effective strategy to 
reduce their anxiety earlier in their treatment cycle. A reduction in anxiety was also 
associated with a weakening of belief in the amenability of HF to control or cure in 
the multivariate analysis (although the relationship between these two variables was 
non-significant in the bivariate correlations). The direction of the relation in the 
multivariate analysis is unexpected and contrary that found between cure/control 
beliefs and mood that is seen in other research (Hagger & Orbell, 2003).  It may be 
something particular to HF as the patients‘ growing acceptance of HF as a chronic 
illness rather than an acute condition may provide some reassurance and lead to 
reductions in anxiety.  
As would be expected, improvement in symptoms was a key factor in 
improved QoL. Change in NYHA class and self-reported symptoms were the 
strongest predictors of change in physical QoL in the 6-months following a diagnosis 
of HF but they were also important predictors of change in emotional QoL. It is 
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important that change in both NYHA class and self-reported symptoms independently 
contributed to explaining change in QoL suggesting that these two factors assess 
different phenomena.  Other studies have also observed that patient reports are 
important predictors of outcome in HF. For example, Ekman and colleagues (2005) 
examined the prognostic significance of self-reported symptoms of breathlessness, 
fatigue, oedema and angina. In a multivariate analysis that included NYHA class 
breathlessness was an independent predictor of increased risk of mortality and all-
cause hospitalisation and fatigue was an independent predictor for the development of 
worsening heart failure.  
Changes in the level of depressed mood and in the severity of perceived 
consequences of HF were also associated with changes in QoL. Despite some 
variability, there was however no overall change in depression in the study sample. It 
is widely recognized that depression is an important predictor of outcome in HF but is 
also under-diagnosed and under-treated (O‘Connor & Joynt, 2004). The findings of 
this study would appear to confirm the importance of depressed mood in affecting 
QoL, and how the early changes in depression are related to changes in QoL. 
Examining and attempting to influence patients‘ mood could provide further benefits 
in QoL in the period following diagnosis.  
Another variable that was significant in explaining change in QoL was change 
in patients‘ beliefs about the severity of the consequences of the illness. These beliefs 
were also predictive of change in mood and were one of the few baseline predictors of 
change in QoL. Addressing patients‘ beliefs about the consequences of their HF early 
in treatment could therefore be another route to enhancing improvements in QoL 
following a diagnosis of HF. Previous attempts to alter patients‘ perceptions about 
their myocardial infarction appear to be successful. In a randomised controlled trial, 
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Petrie et al. (2002) concluded that their in-hospital intervention which was specifically 
designed to change patients‘ illness perceptions resulted in an improved adaptation to 
MI. 
 This study has shown that change in NYHA class and the number of 
symptoms patients attribute to their heart failure account for much of the change in 
QoL in the 6-months following a diagnosis of HF. Nevertheless, change in QoL is not 
only associated with symptoms but also with depression and the severity of the 
consequences that patients perceive HF to have had on their lives. These suggest 
focusing on mood and illness beliefs are potentially additional important ways in 
which HF patients‘ QoL could be improved, irrespective of improvement in control of 
the severity of symptoms. This may be particularly important for those in whom 
medical therapy does not alleviate symptoms to a large degree: in a primary care-
based study from the UK, of those with a confirmed diagnosis of heart failure and 
who were on treatment, none of 449 had no symptoms (NYHA Class I), 63% had 
symptoms on moderate exertion (NYHA Class II), 21% had symptoms on mild 
exertion (NYHA Class III) and 16% had symptoms at rest (Hobbs et al., 2002). 
 
Limitations of the study 
Not all patients were well enough or willing to complete the questionnaires and some 
demographic and clinical differences were found between participants and non-
participants. Of these, age was found to be a significant variable in predicting change 
in QoL therefore the younger age of questionnaire completers may have had some 
impact on study findings. Also, there were too few non-Caucasian patients in the 
study (n = 8, 4.8%) to comment on possible differences in associations in those with a 
different cultural background. 
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We used questionnaires to assess quality of life, illness beliefs, treatment 
beliefs and mood that are generally accepted as reliable, valid and responsive. The 
disease specific health-related quality of life questionnaire, Minnesota Living with 
Heart Failure questionnaire, has been criticized for being insensitive to small changes 
in quality of life (Green et al., 2000).  However, we report a large change in the 
quality of life score in many of the study participants between the two measurement 
points, and a recent meta-analysis has confirmed that this questionnaire is highly 
responsive to changes in control of the heart failure syndrome (Garin et al., 2009).  
 We used the original version of the IPQ, which has been extensively used in 
research that has confirmed the hypothesized associations with psychological 
outcomes and health behaviours. A revised version of the questionnaire has been 
developed (Moss-Morris et al., 2002) which extends the original dimensions and adds 
assessment of emotional representations and illness coherence. However, the items in 
the original measure remain in the revised version so use of the latter may have 
enriched our findings but not overturned them. 
We did not include a measure of coping in the study. The self-regulation 
model (Leventhal et al., 1998) proposes that illness beliefs give rise to coping 
responses, which impact on health outcomes. Assessment of coping may have helped 
to gain a richer understanding of the relationship between changes in illness beliefs 
and their relation to change in mood and QoL in heart failure. 
Questions still remain about the causal direction in the relationship between 
change in illness beliefs and change in QoL. It is quite plausible that change in 
symptoms directly influences QoL and this in turn changes patients‘ illness beliefs. 
The self-regulatory model suggests that adapting to a chronic illness is a dynamic 
process in which all of these interact and influence each other. So for example, while 
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an improvement in symptoms may change a person‘s view about their illness, pre-
existing illness beliefs may influence how a person interprets their symptoms.  
 
Conclusion 
The present study provides an insight into how patients‘ beliefs about their illness and 
treatment, and changes in these variables, affect QoL and mood in the short-term after 
diagnosis and initiation of treatment.   
The study demonstrates that in addition to symptoms, patients‘ emotional state 
and QoL change significantly in the early period following a new diagnosis of heart 
failure. Importantly, the association of these changes with psychological factors 
suggests that closer attention to patients‘ beliefs about their HF and its treatment at the 
time of diagnosis have the potential to improve QoL and aspects of mood at least in 
the short term.    
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Table 1 
Baseline Patient Characteristics  
Demographic  
   N 166 
   Age, median (range) 73 (25-91) 
   Male, n (%) 111 (66.9) 
Clinical  
   Inpatient / outpatient, n (%) 123 (74.1) / 43 (25.9) 
   NYHA class at time of diagnosis, n (%)  
      II 
      III 
      IV 
 
19 (11) 
64 (39) 
83 (50) 
Main comorbidities, n (%) 
      Diabetes mellitus 
      Hypertension 
      COPD/asthma 
      Myocardial infarction 
      Stroke 
      Atrial fibrillation  
 
28 (17) 
80 (48) 
28 (17) 
52 (31) 
15   (9) 
43 (26) 
Discharge medication,  
n (%) prescribed: 
      ACE inhibitors  
      Beta-blockers 
 
 
136 (81.9) 
63 (38.0)   
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Table 2 
New York Heart Association Classification at Time of Diagnosis and 6 Month Follow-up 
NYHA class, n (%) Time of diagnosis 6 month follow-up 
   I 
   II 
   III 
   IV 
0 
19 (11) 
64 (39) 
83 (50) 
45 (27) 
96 (58) 
23 (14) 
  2 (1) 
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Table 3 
Paired t-tests Comparing Baseline and 6 Month Scores 
Variable Baseline 6 months Statistics* 
 Mean SD Mean SD  
Mood 
Anxiety
1 
Depression
1
 
 
6.16 
4.69 
 
4.02 
3.18 
 
4.73 
4.37 
 
3.77 
3.24 
 
t(165df) =  4.96, p<.001 
t(165df) =  1.36, p=.177 
Quality of life 
Physical
2
 
Emotional
3
  
Total score
4
 
 
20.57 
9.03 
41.16 
 
11.31 
6.86 
22.77 
 
11.97 
4.97 
22.40 
 
10.23 
5.79 
19.31 
 
t(165df) =  8.40, p<.001 
t(165df) =  7.43, p<.001 
t(165df) =  9.68, p<.001 
Illness beliefs 
Identity
5
 
Consequences
6
 
Cure/control
7
 
Timeline
8 
 
9.14 
3.08 
3.67 
3.20 
 
4.21 
.59 
.58 
.88 
 
8.01 
3.00 
3.42 
3.61 
 
4.40 
.67 
.59 
.86 
 
t(165df) =  3.12, p=.001 
t(165df) =  1.75, p=.081 
t(165df) =  4.88, p<.001 
t(165df) = -5.42, p<.001 
Treatment beliefs 
Treatment value
9
 
Concerns
10
 
Cure
11
 
Decision satisfaction
12
 
 
4.17 
2.66 
3.13 
4.06 
 
.52 
.76 
.84 
.55 
 
4.20 
2.36 
2.73 
4.07 
 
.55 
.73 
.83 
.56 
 
t(165df) =   -.63, p=.532 
t(165df) =  4.61, p<.001 
t(165df) =  6.08, p<.001 
t(165df) =   -.01, p=.989 
* If a Bonferroni correction is applied to take account of 13 t-tests being performed, (0.05/13 = 0.004), 
a p value < 0.004 is considered statistically significant. 
1
Scale 0-21, higher score = greater depression/anxiety 
2
Scale 0-40, higher score = poorer physical quality of life 
3
Scale 0-25, higher score = poorer emotional of life 
4
Scale 0-105, higher score = poorer quality of life 
5
Scale 0-19, higher score = more reported symptoms, which are attributed to HF 
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6
Scale 1-5, higher score = more serious perceived consequences 
7
Scale 1-5, higher score = stronger belief that HF is amenable to control/cure  
8
Scale 1-5, higher score = longer perceived disease timeline 
9
Scale 1-5, higher score = stronger belief in value of treatment 
10
Scale 1-5, higher score = more concerns about treatment 
11
Scale 1-5, higher score = stronger belief in curative ability of treatment  
12
Scale 1-5, higher score = greater satisfaction with treatment decisions 
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Table 4 
Stepwise Regression Analysis. Baseline Predictors of Change in Quality of Life.   
Variables Β t Adjusted R2 Δ adjusted R2 Power 1 – β 
DV = Change in MLHF total score 
1
 
   Step 1 
   Step 2 
   Step 3 
  
 
.040 
.058 
.113 
 
.040 
.018 
.055 
.99 
 
     COPD .178 2.410*    
     Hypertension .143 1.948*    
     IPQ Consequences .246    3.331***    
DV = Change in MLHF physical subscale 
2
 
   Step 1 
   Step 2 
   Step 3 
   Step 4      
  
 
.043 
.064 
.090 
.116 
 
.043 
.021 
.026 
.026 
.99 
 
 
 
 
     COPD .170 2.288*    
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     Hypertension .151 2.064*    
     IPQ consequences .104 1.301    
     Anxiety .192 2.389*    
DV = Change in MLHF emotional subscale
 3
       1.00 
   Step 1   .030 .030  
   Step 2   .085 .055  
   Step 3   .108 .023  
   Step 4      .139 .031  
     Age -.157    -2.051*    
     COPD .215  2.943**    
     Hypertension .153 2.098*    
     IPQ consequences .199   2.601**    
Note. Only β and t values from the final step of the equations are shown. 
1
Step 1: COPD, Step 2: COPD, Hypertension.   
2
Step 1: COPD, Step 2: COPD, Hypertension, Step 3: COPD, Hypertension, IPQ consequences.  
3
Step 1: Age, Step 2: Age, COPD, Step 3: Age, COPD, Hypertension. 
*p≤.05, ** p≤.01, *** p≤.001 
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Table 5 
Stepwise Regression Analysis. Influence of Change in Symptoms and Beliefs on Change in Mood 
Variables β T Adjusted R2 Δ adjusted R2 Power 1 – β 
DV = Anxiety 
1
     1.00 
   Step 1   .041 .041  
   Step 2   .241 .200  
   Step 3   .324 .083  
   Step 4   .358 .034  
   Step 5   .387 .029  
     Hypertension -.111   -1.753    
     TRI concerns     .290   4.308***    
     IPQ identity .329   4.880***    
     IPQ cure .207   3.365***    
     IPQ consequences .190 2.907**    
DV = Depression
2
  1.00 
   Step 1   .131 .131  
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   Step 2   .188 .057  
   Step 3   .222 .034  
   Step 4   .237 .015  
     NYHA .236  3.232***    
     IPQ identity .227 3.126**    
     IPQ consequences .194 2.746**    
     TRI cure       -.143   -2.065*    
1
Step 1: Hypertension, Step 2: Hypertension, TRI emotion, Step 3: Hypertension, TRI emotion, IPQ identity, Step 4: Hypertension, TRI emotion, IPQ identity, IPQ cure. 
2
Step 1: NYHA, Step 2: NYHA, IPQ identity, Step 3: NYHA, IPQ identity, IPQ consequences. 
*p≤.05, ** p≤.01, *** p≤.001 
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Table 6 
Stepwise Regression Analysis. Relationship between Change in Symptoms, Beliefs and Mood and Change in Quality of Life  
Variables β T Adjusted R2 Δ adjusted R2 Power 1 – β 
DV = Change in MLHF total score 
1
     1.00 
   Step 1   .040 .040  
   Step 2   .058 .018  
   Step 3   .247 .189  
   Step 4   .369 .122  
   Step 5   438 .069  
   Step 6   .472 .034  
     COPD -.121    2.123*    
     Hypertension -.015 .260    
     NYHA .243  3.881***    
     IPQ identity .285  4.500***    
     IPQ consequences .233  3.873***    
     Depression .219  3.380***    
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 DV = Change in MLHF physical subscale 
2
  1.00 
   Step 1   .043 .043  
   Step 2   .064 .021  
   Step 3   .325 .261  
   Step 4   .436 .111  
   Step 5   .471 .035  
   Step 6   .494 .023  
     COPD -.126 2.248*    
     Hypertension -.024 .414    
     NYHA .342   5.576***    
     IPQ identity .291   4.686***    
     IPQ consequences .163  2.772**    
     Depression .181  2.853**    
DV = Change in MLHF emotional subscale
3
  1.00 
   Step 1   .030 .030  
   Step 2   .085 .055  
 34 
   Step 3   .108 .023  
   Step 4   .215 .107  
   Step 5   .319 .104  
   Step 6   .332 .013  
   Step 7   .378 .046  
   Step 8   .399 .021  
     Age -.309   -4.762***    
     COPD -.158  2.582**    
     Hypertension -.043 .686    
     NYHA .191 2.714**    
     IPQ identity .203 2.804**    
     IPQ consequences .043 .643    
     Anxiety     .217 2.934**    
     Depression .183 2.572**    
1
 Step 1: COPD, Step 2: COPD, Hypertension, Step 3: COPD, Hypertension, NYHA, Step 4: COPD, Hypertension, NYHA, IPQ identity, Step 5: COPD, Hypertension, 
NYHA, IPQ identity, IPQ consequences. 
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2
 Step 1: COPD, Step 2: COPD, Hypertension, Step 3: COPD, Hypertension, NYHA, Step 4: COPD, Hypertension, NYHA, IPQ identity, Step 5: COPD, Hypertension, 
NYHA, IPQ identity, IPQ consequences. 
3
 Step 1: Age, Step 2: Age, COPD, Step 3: Age, COPD, Hypertension, Step 4: Age, COPD, Hypertension, NYHA, Step 5: Age, COPD, Hypertension, NYHA, IPQ identity, 
Step 6: Age, COPD, Hypertension, NYHA, IPQ identity, IPQ consequences, Step 7: Age, COPD, Hypertension, NYHA, IPQ identity, IPQ consequences, Anxiety. 
*p≤.05, ** p≤.01, *** p≤.001 
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Figure 1 
Percentage of Patients Reporting Symptoms that they Attributed to HF (IPQ Identity) 
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